Key insights
- Projected mRNA product revenues worldwide in 2021
- bn USD

Detailed statistics
Forecasted revenue of mRNA market revenue worldwide 2021-2035
- Projected COVID-19 vaccine share of total mRNA product revenues worldwide in 2021
- 100%

Detailed statistics
Forecasted COVID-19 vaccine share of total mRNA revenues globally 2021-2035
- Forecasted sales of BioNTech/Pfizer vaccine Comirnaty in 2021
- 36 bn USD

Detailed statistics
Forecasted sales of select COVID-19 vaccines worldwide 2021-2022
·¡»å¾±³Ù´Ç°ù’s Picks
·¡»å¾±³Ù´Ç°ù’s Picks
Current statistics on this topic
Recommended statistics
Overview
5
- Global pharmaceutical revenue by technology 2012-2026
- Percentage of global pharmaceutical sales by technology 2016-2030
- Leading pharma and biotech companies in 2024, by net sales growth
- Leading 50 global pharmaceutical and biotech companies 2024, by R&D intensity
- Forecasted revenue of mRNA market revenue worldwide 2021-2035
Overview
-
Global pharmaceutical revenue by technology 2012-2026

Global pharmaceutical revenue by technology 2012-2026
Global pharmaceutical revenue distributed by technology from 2012 to 2026 (in billion U.S. dollars)
-
Percentage of global pharmaceutical sales by technology 2016-2030

Percentage of global pharmaceutical sales by technology 2016-2030
Distribution of global pharmaceutical sales from 2016 to 2030, by technology
-
Leading pharma and biotech companies in 2024, by net sales growth

Leading pharma and biotech companies in 2024, by net sales growth
Leading 50 pharmaceutical and biotechnology companies worldwide in 2024, by net sales growth
-
Leading 50 global pharmaceutical and biotech companies 2024, by R&D intensity

Leading 50 global pharmaceutical and biotech companies 2024, by R&D intensity
Leading 50 pharmaceutical and biotechnology companies worldwide in 2024, by R&D intensity
-
Forecasted revenue of mRNA market revenue worldwide 2021-2035

Forecasted revenue of mRNA market revenue worldwide 2021-2035
Forecasted mRNA product revenue worldwide from 2021 to 2035 (in billion U.S. dollars)
Research and development
5
- Global funding in mRNA therapeutics and vaccines 2015-2020
- Clinical pipeline of mRNA therapeutics worldwide by therapy area 2021
- Clinical pipeline of mRNA prophylactic vaccines worldwide by therapy area 2021
- Clinical pipeline of mRNA therapeutic vaccines worldwide by therapy area 2021
- mRNA technology clinical pipelines worldwide by therapy area and stage 2021
Research and development
-
Global funding in mRNA therapeutics and vaccines 2015-2020

Global funding in mRNA therapeutics and vaccines 2015-2020
Global funding on mRNA therapeutics and vaccines from 2015 to 2020 (in million U.S.dollars)
-
Clinical pipeline of mRNA therapeutics worldwide by therapy area 2021

Clinical pipeline of mRNA therapeutics worldwide by therapy area 2021
Number of mRNA therapeutics in clinical pipelines worldwide as of July 2021, by therapy area
-
Clinical pipeline of mRNA prophylactic vaccines worldwide by therapy area 2021

Clinical pipeline of mRNA prophylactic vaccines worldwide by therapy area 2021
Number of mRNA prophylactic vaccines in clinical pipelines worldwide as of July 2021, by therapy area
-
Clinical pipeline of mRNA therapeutic vaccines worldwide by therapy area 2021

Clinical pipeline of mRNA therapeutic vaccines worldwide by therapy area 2021
Number of mRNA therapeutic vaccines in clinical pipelines worldwide as of July 2021, by therapy area
-
mRNA technology clinical pipelines worldwide by therapy area and stage 2021

mRNA technology clinical pipelines worldwide by therapy area and stage 2021
Share of mRNA technology in clinical pipelines worldwide as of July 2021, by therapy area and development phase
COVID-19
6
- Forecasted COVID-19 vaccine share of total mRNA revenues globally 2021-2035
- Forecasted COVID-19 vaccine revenue share globally by technology 2026
- Bestselling COVID-19 vaccines and drugs worldwide in 1st HY 2021
- Drugs generating 10 billion U.S. dollars or more in annual sales worldwide 2021
- Forecasted sales of select COVID-19 vaccines worldwide 2021-2022
- COVID-19 vaccine development, enrollment and funding status July 28, 2020, by company
COVID-19
-
Forecasted COVID-19 vaccine share of total mRNA revenues globally 2021-2035

Forecasted COVID-19 vaccine share of total mRNA revenues globally 2021-2035
Share of COVID-19 vaccine revenue of total forecasted mRNA product revenue worldwide from 2021 to 2035
-
Forecasted COVID-19 vaccine revenue share globally by technology 2026

Forecasted COVID-19 vaccine revenue share globally by technology 2026
Forecasted share of COVID-19 vaccine revenue worldwide in 2021 and 2026, by technology
-
Bestselling COVID-19 vaccines and drugs worldwide in 1st HY 2021

Bestselling COVID-19 vaccines and drugs worldwide in 1st HY 2021
Bestselling COVID-19 vaccines and drugs worldwide in 1st HY 2021 (in billion U.S. dollars)
-
Drugs generating 10 billion U.S. dollars or more in annual sales worldwide 2021

Drugs generating 10 billion U.S. dollars or more in annual sales worldwide 2021
Drugs that generated 10 billion U.S. dollars or more in annual sales worldwide as of 2021 (in billion U.S. dollars)
-
Forecasted sales of select COVID-19 vaccines worldwide 2021-2022

Forecasted sales of select COVID-19 vaccines worldwide 2021-2022
Forecasted sales of select COVID-19 vaccines worldwide in 2021 and 2022 (in billion U.S. dollars)
-
COVID-19 vaccine development, enrollment and funding status July 28, 2020, by company

COVID-19 vaccine development, enrollment and funding status July 28, 2020, by company
Phase 3 enrollment and BARDA/Warp Speed funding status for select COVID-19 vaccines, as of July 28, 2020, by company
Leading companies
-
Leading mRNA biotech companies' revenues 2022

Leading mRNA biotech companies' revenues 2022
Revenues of leading mRNA biotech companies in 2020 and 2022 (in million U.S.dollars)
-
Leading mRNA biotech companies' net income 2022

Leading mRNA biotech companies' net income 2022
Net income of leading mRNA biotech companies in 2020 and 2022 (in million U.S.dollars)
-
Leading mRNA biotech companies' R&D spending 2022

Leading mRNA biotech companies' R&D spending 2022
R&D spending of leading mRNA biotech companies in 2020 and 2022 (in million U.S.dollars)
-
Leading mRNA biotech companies' market cap 2026

Leading mRNA biotech companies' market cap 2026
Market capitalization of leading mRNA biotech companies between March 2023 and March 2026 (in billion U.S.dollars)
Focus: Moderna
-
Moderna's revenue 2016-2025

Moderna's revenue 2016-2025
Revenue of Moderna Inc. from 2016 to 2025 (in million U.S. dollars)
-
Moderna net income 2016-2024

Moderna net income 2016-2024
Moderna Inc.'s net income from 2016 to 2024 (in million U.S. dollars)
-
R&D expenses of Moderna 2016-2024

R&D expenses of Moderna 2016-2024
Research and development expenses of Moderna Inc. from 2016 to 2024 (in million U.S. dollars)
-
Moderna total assets 2016-2024

Moderna total assets 2016-2024
Total assets of Moderna Inc. from 2016 to 2024 (in million U.S. dollars)
-
Net Present Value of Moderna products worldwide 2021

Net Present Value of Moderna products worldwide 2021
Net Present Value (NPV) of Moderna products worldwide as of August 2021 (in million U.S. dollars)
Focus: BioNTech
-
Revenue of BioNTech 2017-2025

Revenue of BioNTech 2017-2025
Revenue of BioNTech SE from 2017 to 2025 (in million euros)
-
Operating income of BioNTech 2017-2024

Operating income of BioNTech 2017-2024
Operating income of BioNTech SE from 2017 to 2024 (in million euros)
-
BioNTech earnings per share 2017-2024

BioNTech earnings per share 2017-2024
Earnings per share of BioNTech SE from 2017 to 2024 (in euros)
-
BioNTech total assets 2017-2025

BioNTech total assets 2017-2025
Total assets of BioNTech SE from 2017 to 2025 (in million euros)
Further reports
Get the best reports to understand your industry
Get in touch with us for additional information
Feel free to contact us anytime. We will respond to your inquiry as quickly as possible.






